Texas Society of Psychiatric Physicians
“Enhancing Psychiatric Practice: Evidence-Based Tools for Metabolic, Behavioral, and Sleep Health”
November 8-9, 2025
9 AMA PRA Category 1 CreditsTM,
with 2.5 of the Hours Designated for Medical Ethics/Professional Responsibility
Saturday, November 8, 2025
| 8:15 am – 8:30 am |
Opening Remarks |
| 8:30 am – 9:30 am |
Rewiring Psychiatry: A New Role for GLP-1 Receptor Agonists – Poorvanshi Alag, MD, DABOM |
|
Objectives: The learning objectives for this activity have been designed to address clinician competence. Upon conclusion of the activity participants should be able to:
–Describe the pharmacological mechanisms and current indications of GLP-1 receptor agonists relevant to psychiatric practice.
–Evaluate the risks, benefits, and clinical considerations of prescribing GLP-1 receptor agonists in patients with co-occurring psychiatric and metabolic conditions.
–Formulate practical strategies for incorporating GLP-1 receptor agonists into individualized psychiatric treatment plans, including when to refer or collaborate with other specialties. |
| 9:30 am – 9:50 am |
Refreshment Break with Exhibitors and Poster Session |
| 9:50 am – 11:50 am |
Sleep Medicine: Disorders, Diagnostic Tests, and Treatments – Abha Patel, MD
|
|
Objectives: The learning objectives for this activity have been designed to address clinician competence. Upon conclusion of the activity participants should be able to:
– .Be familiar with the range of possible sleep disorders.
–Know when to refer to a sleep specialist.
–Be confident treating some sleep disorders, like insomnia, without specialist referral.
–Understand which sleep studies to order and how to interpret them.
–Select appropriate medications and non-pharmacological options (e.g., CPAP, dental devices). |
| 11:50 am – 12:10 pm |
Refreshment Break with Door Prize Drawings, Exhibitors and Poster Session |
| 12:10 pm – 1:20 pm |
Federation Annual Business Meeting Lunch |
| 1:30 pm – 3:00 pm |
Understanding the Morbidity and Mortality of Eating Disorders – Susan Mengden, PhD |
|
Objectives: The learning objectives for this activity have been designed to address clinician competence. Upon conclusion of the activity participants should be able to:
–Better identify eating disorders.
–Understand treatments available for Eating Disorders, to include intensive outpatient treatment, residential treatment, inpatient hospitalization, medical hospitalization. |
| 3:00 pm – 3:15 pm |
Refreshment Break with Door Prize Drawings, Exhibitors and Poster Session |
| 3:15 pm – 4:15 pm |
Cognitive-Behavioral Therapy for Insomnia – Jessica Klement, PhD
|
|
4:25 pm – 5:25 pm
|
Objectives: The learning objectives for this activity have been designed to address clinician competence. Upon conclusion of the activity participants should be able to:
–Identify key evidence-based components of CBT-I and their role in improving sleep and psychiatric symptoms.
–Determine which patients are appropriate candidates and when CBT-I may need modification or is contraindicated.
–Describe strategies to build motivation for behavioral treatment in patients accustomed to medication treatment only.
–Refer patients to qualified CBT-I providers and resources, including telehealth options.
Nutrition and Mental Health – Jaclyn Albin, MD, CCMS, DipABLM
Objectives: The learning objectives for this activity have been designed to address clinician competence. Upon conclusion of the activity participants should be able to:
–Recognize the role of nutrition in mental health.
–Name the evidence-based diets/dietary patterns.
–List supplements used in psychiatric illness.
–Apply assessment of a patient’s diet quality and address barriers to making changes.
|
| 5:25 pm – 5:35 pm |
Closing Remarks |
Sunday, November 9, 2025
| 8:15 am – 8:30 am |
Opening Remarks |
| 8:30 am – 10:00 am |
Ethics: Law Enforcement and Psychiatry: Controlled Substance Prescribing – Gary Linder, A/DPM (DEA Representative) |
|
Objectives: The learning objectives for this activity have been designed to address clinician competence. Upon conclusion of the activity participants should be able to:
–Have full knowledge of prescribing rules and limitations for controlled substances.
–Gain understanding and implementation of Take Back programs for medications that patients no longer need.
–Have knowledge on application of Ryan Haight Act in prescribing of controlled substances. |
| 10:00 am – 10:20 am |
Refreshment Break |
| 10:20 am – 11:20 am |
Ethics: Integrating the Safety-A Suicide Assessment Program into Clinical Practice Enhancing Risk Formulation and Intervention – Colleen Neal, PMHNP-BC |
|
Objectives: The learning objectives for this activity have been designed to address clinician competence. Upon conclusion of the activity participants should be able to:
–Explain the theoretical foundation and clinical rationale behind the Safety-A Suicide Assessment Program, including its relevance to clinical care.
–Integrate the Safety-A protocol into clinical evaluations to support structured, evidence-informed suicide risk assessments.
–Utilize the Safety-A framework to guide collaborative safety planning, documentation, and appropriate levels of care across diverse practice settings. |
| 11:20 am – 11:30 am |
Closing Remarks |
CME PROGRAM GOAL / TARGET AUDIENCE This live activity has been designed in a format consisting of case study presentations, lectures and direct discussion to provide its primary target audience of Psychiatrists, as well as other specialties of medicine, with the most up-to-date, evidence-based data that can be translated into clinical practice. Information and data will address new developments in treatments and new directions in research to address the professional practice gaps of the learners and advance the physicians’ competence and effective use of targeted skills so that they may develop strategies to apply the knowledge, skills and judgement of the information presented in the educational activity into their practice. The learning objectives for this activity have been designed to address clinician competence.
NEEDS ASSESSMENT TSPP has incorporated into this CME activity the relevant educational needs concerning competence that underlie the professional practice gaps of our participants.
ACCREDITATION STATEMENT The Texas Society of Psychiatric Physicians is accredited by the Texas Medical Association to provide continuing medical education for physicians.
CREDIT STATEMENT The Texas Society of Psychiatric Physicians designates this Live Activity for a maximum of nine (9) AMA PRA Category I CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
ETHICS DESIGNATION STATEMENT The presentation entitled “Law Enforcement and Psychiatry: Controlled Substance Prescribing” has been designated by the Texas Society of Psychiatric Physicians for one and half (1.5) hours of education in medical ethics and/or professional responsibility. The presentation entitled “Integrating the Safety-A Suicide Assessment Program into Clinical Practice Enhancing Risk Formulation and Intervention” has been designated by the Texas Society of Psychiatric Physicians for one (1) hour of education in medical ethics and/or professional responsibility.
FACULTY AND PLANNERS DISCLOSURE POLICY The Texas Society of Psychiatric Physicians will disclose to participants the existence of any relevant financial relationships between faculty members, TSPP staff and members, who planned, authored, contributed to, and/or reviewed the content of this activity, and any commercial interest discussed in this educational activity. Disclosure will occur through written communication in the syllabus/handout material.
CANCELLATION POLICY: In the event of cancellation, a full refund will be made if written notice is received in the TSPP office by October 10, 2025, less a 25% processing charge. NO REFUNDS will be given after October 10, 2025.